MC
BDSI

Menta Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Menta Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-95,110
Closed -$224K – 1085
2016
Q2 		$224K Buy
+95,110
New +$262K 0.03% 759
2015
Q2 		– Sell
-57,100
Closed -$600K – 866
2015
Q1 		$600K Buy
57,100
+20,600
+56% +$281K 0.08% 400
2014
Q4 		$439K Sell
36,500
-1,600
-4% -$24.3K 0.06% 459
2014
Q3 		$651K Buy
38,100
+1,100
+3% +$16K 0.11% 303
2014
Q2 		$447K Buy
+37,000
New +$351K 0.08% 313

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Menta Capital's BDSI Position: Q3 2016 in Review

Menta Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2016, closing a stake of 95,110 shares — an estimated $224K sold.

Menta Capital first reported a position in BDSI in Q2 2014 and held it in 5 quarters. The position peaked at $651K in Q3 2014. 85 funds tracked by Wall St. Rank hold BDSI as of Q3 2016.

  • Menta Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2016 after selling out during the quarter.
  • Menta Capital sold 95,110 BioDelivery Sciences International, Inc. shares in Q3 2016, an estimated $224K.
  • Menta Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 5 quarters.
  • Menta Capital's BioDelivery Sciences International, Inc. position peaked at $651K in Q3 2014.
  • 85 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2016.

Based on Menta Capital's 13F filing for Q3 2016, filed 14 Nov 2016.